SONM

DNA X

• TipRanks·08/31 21:19

  Sonim Technologies Maintains Nasdaq Compliance Amid Monitoring Period

• TipRanks·08/27 11:58

  Sonim Technologies Adopts Cash-Based Director Compensation Structure

• NASDAQ·08/20 09:37

  DNA X Posts Q2 Results, Balance Sheet Restructuring Supports AI Platform Transition

• Seeking Alpha·08/19 20:18

  DNA X, Inc GAAP EPS of -$0.92

• Dow Jones·08/19 20:15

  Press Release: DNA X, Inc. Reports Second Quarter 2026 Financial Results

• Dow Jones·08/19 20:15

  Press Release: DNA X, Inc. Reports Second Quarter -2-

• TipRanks·08/14 22:25

  Sonim Technologies delays quarterly filing amid consolidation

• TipRanks·07/02 13:28

  Sonim Technologies Strengthens Capital Structure With Preferred Financing

• TipRanks·06/04 22:47

  Sonim Technologies Ends Major Equity Purchase Agreement

• TipRanks·05/27 21:43

  Sonim Technologies Faces Nasdaq Delisting After New Financing

• Seeking Alpha·05/21 14:34

  DNA X, Inc reports Q1 results

• TipRanks·05/15 23:31

  DNA X, Inc. Delays Quarterly Filing After Asset Sale

• Seeking Alpha·04/15 07:41

  DNA X GAAP EPS of -$11.00

• TipRanks·04/01 18:25

  DNA X, Inc. delays 2025 annual filing

• TipRanks·02/10 21:56

  Sonim Technologies Names Mike Mulica Acting Chief Executive